Accessibility helpSkip to navigationSkip to contentSkip to footer

Cookies on FT Sites

We use cookies and other data for a number of reasons, such as keeping FT Sites reliable and secure, personalising content and ads, providing social media features and to analyse how our Sites are used.

Accept cookies
Manage cookies
  • Sign In
  • Subscribe
Open side navigation menuOpen search bar
Financial Times
SubscribeSign InmyFT
  • Home
  • World
    Sections
    • World Home
    • Global Economy
    • UK
    • US
    • China
    • Africa
    • Asia Pacific
    • Emerging Markets
    • Europe
    • War in Ukraine
    • Americas
    • Middle East & North Africa
    • Australia & NZ
    Most Read
    • Ukraine sends western tanks into battle as counter-offensive gets under way
    • Donald Trump says he has been indicted on federal charges in documents probe
    • Erdoğan taps former Goldman Sachs banker to head Turkey’s central bank
    • Canadian wildfire smoke jars New York with ‘movie of the future’
    • Norway seeks to open vast ocean area to deep-sea mining
  • US
    Sections
    • US Home
    • US Economy
    • US Companies
    • US Politics & Policy
    Most Read
    • Companies
      Sections
      • Companies Home
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
      Most Read
      • FCA investigates Odey Asset Management
      • Goldman, Exane and Schroders cut ties with Odey Asset Management after assault claims
      • Anne Boden stepped down as Starling CEO after investor clash
      • LetterOne chair Mervyn Davies receives bumper payout after Russian oligarchs’ exit
      • The Pirelli boss taking on China’s Communist party
    • Tech
    • Markets
      Sections
      • Markets Home
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
      Most Read
      • Live news: Putin says Ukraine’s counteroffensive is under way
      • Goldman, Exane and Schroders cut ties with Odey Asset Management after assault claims
      • FCA investigates Odey Asset Management
      • Norway seeks to open vast ocean area to deep-sea mining
      • UK set to introduce floor for oil and gas windfall tax
    • Climate
    • Opinion
      Sections
      • Opinion Home
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
      Most Read
      • How US cities became one big parking lot
      • Apple’s Vision Pro headset has made the metaverse feel outdated
      • Trump indictment brings him closer to the danger zone
      • Investors must beware deepfake market manipulation
      • Ukraine’s dam explosion is a red line: Russia must feel the consequences
    • Work & Careers
      Sections
      • Work & Careers Home
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
      Most Read
      • Too good to be true? The fake recruiters targeting jobseekers
      • Can a virtual PA turbocharge your career?
      • Anti-monarchist Graham Smith: The British royals are ‘tax-funded Kardashians’
      • FT business books: what to read this month
    • Life & Arts
      Sections
      • Life & Arts Home
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
      Most Read
      • How Crispin Odey evaded sexual assault allegations for decades
      • François Hollande: ‘Putin cannot be seduced. He respects force’
      • Grand Seiko’s rock star of watchmaking
      • Don’t blame us for AI’s threat to humanity, we’re just the technologists
      • Confessions of a food award judge
    • HTSI
    MenuSearch
    • Home
    • World
    • US
    • Companies
    • Tech
    • Markets
    • Climate
    • Opinion
    • Work & Careers
    • Life & Arts
    • HTSI
    Financial Times
    SubscribeSign In

    Covid-19 vaccines

    Add to myFT Digest

    Add this topic to your myFT Digest for news straight to your inbox

    • Friday, 26 May, 2023
      Brussels and Pfizer agree deal to cut supply of Covid vaccines

      Revised contract addresses concerns over costly glut of unwanted shots as public health threat wanes

    • Sunday, 14 May, 2023
      Novavax Inc
      Cash-strapped Novavax urges governments to honour Covid jab deals

      US biotech group is among coronavirus vaccine makers struggling with reduced demand post-pandemic

    • Friday, 12 May, 2023
      Simon Schama
      The thwarting of science will always be a human failing

      From India to Britain, we have always managed to get in the way of our own inventiveness

    • Tuesday, 9 May, 2023
      Janan Ganesh
      The west’s handling of the pandemic beat its own expectations

      A demonised elite produced vaccines and furloughs while a supposedly rebellious public mostly followed the rules

    • Monday, 1 May, 2023
      Noubar Afeyan
      Moderna co-founder calls on US politicians and judges to stop questioning science

      Noubar Afeyan says court rulings on abortion pills and access to healthcare undermine efforts to combat diseases

    • Sunday, 30 April, 2023
      BioNTech/Pfizer’s mooted EU deal for 70mn Covid shots threatens rivals

      European health officials have advocated portfolio diversity to help fight different variants

    • Friday, 28 April, 2023
      Special ReportThe Americas’ Fastest Growing Companies
      Moderna tries to show it’s not a ‘one trick pony’

      Covid vaccine maker is sitting on $18bn and embarking on a host of ambitious projects

    • Wednesday, 26 April, 2023
      Pharmaceuticals sector
      EU aims to create ‘single market for medicines’ with overhaul of pharma rules

      Revamp that would cut drugmakers’ years of market exclusivity meets fierce opposition from sector

    • Monday, 24 April, 2023
      EU business regulation
      EU outlines plan to take control of medicine production in health crises

      Proposal for compulsory licensing risks ire of pharma groups keen to protect patents and revenue

    • Monday, 27 March, 2023
      BioNTech
      BioNTech forecasts slump in sales as demand for Covid jab wanes

      Expected fall highlights challenges for pharmaceutical companies that experienced pandemic windfall

    • Wednesday, 15 March, 2023
      Taiwan
      Taiwan loses diplomatic ally as Honduras confirms link to China

      Central American nation was one of Taipei’s last partners in Washington’s backyard

    • Tuesday, 14 March, 2023
      Pfizer’s revised EU Covid vaccine contract meets resistance

      Four member states including Poland say amended deal is not ‘fair solution’ to surplus of shots

    • Tuesday, 7 March, 2023
      UK spring Covid boosters will target elderly and vulnerable

      Health secretary confirms acceptance of advice from expert committee to ‘bridge the gap’ to autumn

    • Wednesday, 15 February, 2023
      CanSino says vaccine demand down after China’s mass Covid infections

      Pharma group hopes for approval of mRNA vaccine for booster shots

    • Sunday, 29 January, 2023
      Drugs research
      RQ Bio partners with AstraZeneca in Covid antibody fight

      UK biotech racing to keep antibody up to date with latest variants

    • Tuesday, 10 January, 2023
      Chinese bank tries to entice wealthy customers with mRNA vaccines

      Hong Kong-based lender seeks to cater to mainlanders’ demand for western jabs

    • Monday, 9 January, 2023
      CureVac GmbH
      Covid vaccine makers CureVac and Novavax appoint new chiefs

      Pharmaceutical groups to part ways with longstanding executives

    • Monday, 9 January, 2023
      InterviewPharmaceuticals sector
      SK Bioscience says ‘national pride’ prevents China from accepting foreign Covid jabs

      South Korean vaccine maker looks elsewhere to expand overseas business

    • Friday, 6 January, 2023
      New Chinese mRNA Covid vaccine shows positive early results

      Jab developed by CanSinoBio could help nation grappling with a wave of infection

    • Thursday, 5 January, 2023
      ExplainerCoronavirus
      How serious is the threat of new Covid-19 variants?

      A surge in cases after China lifted restrictions has sparked concerns that a dangerous new strain could emerge

    • Tuesday, 3 January, 2023
      EU offers free Covid-19 vaccines to China to help curb outbreak

      Beijing rejects Brussels’ offer, citing full control of situation

    • Monday, 26 December, 2022
      Chinese society
      Chinese vaccine tourists flock to Macau for mRNA Covid jabs

      Explosion of cases and ban on more effective western shots lead residents to look abroad

    • Monday, 12 December, 2022
      China warned to accelerate approval of updated jabs to tackle Covid ‘tsunami’

      Authorities have relied on vaccines made using original strain found in Wuhan

    • Wednesday, 7 December, 2022
      Coronavirus
      China risks ‘wave of infections’ after relaxing zero-Covid policy, warns Fauci

      Joe Biden’s chief medical adviser urges Beijing to approve use of western vaccines

    • Tuesday, 6 December, 2022
      News in-depthChinese politics & policy
      China’s elderly vaccine refuseniks pose obstacle for Xi Jinping

      Nearly 90mn Chinese are insufficiently protected against Covid as Beijing begins to unwind pandemic controls

    Previous page You are on page 1 Next page

    Recommended

    Covid-19 vaccine tracker: Lowest-income countries lag further behind rest of the world
    Covid vaccine development: The shots available and the doses administered
    In graphics: the UK vaccine supply chain
    Coronavirus: free to read
    Coronavirus tracker: the latest figures as countries fight the Covid-19 resurgence

    Be part of FT Community

    Discover unmissable flagship events and members only communities to expand your thinking and elevate your career

    FT Live
    Can Reducing Inequality Lower the Risk of Pandemics?
    Addressing social and economic divides to end AIDS and prevent future pandemics
    Tuesday, 20th JuneOnline
    FT Live
    Global Pharma and Biotech Summit
    Driving Investment and Innovation in Life Sciences
    Tuesday, 7th NovemberUK & Online
    Learn more about FT Community

    Useful links

    Support

    View Site TipsHelp CentreContact UsAbout UsAccessibilitymyFT TourCareers

    Legal & Privacy

    Terms & ConditionsPrivacy PolicyCookiesCopyrightSlavery Statement & Policies

    Services

    Share News Tips SecurelyIndividual SubscriptionsGroup SubscriptionsRepublishingExecutive Job SearchAdvertise with the FTFollow the FT on TwitterFT ChannelsFT Schools

    Tools

    PortfolioToday's Newspaper (ePaper)Alerts HubBusiness School RankingsEnterprise ToolsNews feedNewslettersCurrency Converter

    Community & Events

    FT CommunityFT Live EventsFT ForumsFT Board DirectorBoard Director Programme

    More from the FT Group

    Markets data delayed by at least 15 minutes. © THE FINANCIAL TIMES LTD 2023. FT and ‘Financial Times’ are trademarks of The Financial Times Ltd.
    The Financial Times and its journalism are subject to a self-regulation regime under the FT Editorial Code of Practice.
    Financial Times

    International Edition

    Subscribe for full access
    • Switch to UK Edition

    Top sections

    • Home
    • World
      • Global Economy
      • UK
      • US
      • China
      • Africa
      • Asia Pacific
      • Emerging Markets
      • Europe
      • War in Ukraine
      • Americas
      • Middle East & North Africa
      • Australia & NZ
    • US
      • US Economy
      • US Companies
      • US Politics & Policy
    • Companies
      • Energy
      • Financials
      • Health
      • Industrials
      • Media
      • Professional Services
      • Retail & Consumer
      • Tech Sector
      • Telecoms
      • Transport
    • Tech
    • Markets
      • Alphaville
      • Markets Data
      • Cryptofinance
      • Capital Markets
      • Commodities
      • Currencies
      • Equities
      • Fund Management
      • Trading
      • Moral Money
      • ETF Hub
    • Climate
    • Opinion
      • Columnists
      • The FT View
      • Lex
      • Obituaries
      • Letters
    • Work & Careers
      • Business School Rankings
      • Business Education
      • Entrepreneurship
      • Recruitment
      • Business Books
      • Business Travel
    • Life & Arts
      • Arts
      • Books
      • Food & Drink
      • FT Magazine
      • House & Home
      • Style
      • Travel
      • FT Globetrotter
    • Personal Finance
      • Property & Mortgages
      • Investments
      • Pensions
      • Tax
      • Banking & Savings
      • Advice & Comment
      • Next Act
    • HTSI
    • Special Reports

    FT recommends

    • Lex
    • Alphaville
    • Lunch with the FT
    • FT Globetrotter
    • #techAsia
    • Moral Money
    • Newsletters
    • Video
    • Podcasts
    • News feed
    • FT Live Events
    • FT Forums
    • Board Director Programme
    • myFT
    • Portfolio
    • Today's Newspaper (ePaper)
    • Crossword
    • Our Apps
    • Help Centre
    • Subscribe
    • Sign In